Mednet Logo
HomePediatric Hematology/Oncology
Pediatric Hematology/Oncology

Pediatric Hematology/Oncology

Clinical discussions on pediatric blood disorders, childhood cancers, and specialized treatment protocols.

Recent Discussions

How do you approach autologous stem cell transplant in T-cell lymphomas/PTCL after induction chemotherapy with achievement of CR1?

1
1 Answers

Mednet Member
Mednet Member
Hematology · UMass Chan Medical School

Autologous SCT can be considered in PTCL in CR1 especially if the patient is MRD negative by PET and molecular testing (by checking for the persistence of clonal T cells, for example). Schmitz et al., PMID 33512419 If MRD positive CR or PR/SD, would consider allogeneic SCT instead. The main concern ...

In a young female with severe osteoporosis due to congenital estrogen deficiency, can estrogen be prescribed if genetic testing for congenital disorders reveals a heterozygous Factor V Leiden mutation?

2
1 Answers

Mednet Member
Mednet Member
Hematology · University of Wisconsin

First of all, I don't think testing for inherited thrombophilia is warranted in a patient with no personal or family history of thrombosis. Given the multigenic nature of thrombophilia and our limited ability to test for it, it's difficult if not impossible to determine an individual's risk of throm...

What is the risk of serious bacterial infection in a febrile solid tumor patient who has not yet started cancer-directed therapy and has normal cell counts with no central line?

1 Answers

Mednet Member
Mednet Member
Pediatric Hematology/Oncology · Kidz Medical Services, Inc

This depends on the type of the tumor, the location, and the individual circumstances. It may not be wrong in this scenario to draw blood cultures and give a dose of ceftriaxone pending 24-hour results, but this practice may also vary based on these different variables e.g. RMS of paranasal-ear area...

Do you offer iron supplementation to a patient with iron studies that are normal (including normal ferritin) except for low iron saturation?

1 Answers

Mednet Member
Mednet Member
Hematology · Georgetown University School of Medicine

The answer is absolutely and positively yes. A low percent saturation of transferrin has an extremely high concordance with absent marrow hemosiderin and frankly, in today’s parlance is the best indicator of “iron need”. While the ferritin is marvelous at confirming iron deficiency if low (with or w...

What is your preferred conditioning regimen for fit patients with high-risk MDS undergoing MUD allogeneic stem cell transplantation?

1 Answers

Mednet Member
Mednet Member
Medical Oncology · University of Maryland Cancer Center

The short answer is whatever MAC regimen you and your center are familiar with and comfortable managing the side effects. I would definitely think of a myeloablative regimen rather than a reduced intensity one. For HLA-matched donor, I usually give MAC Bu4Flu with Bu PK to tailor the Bu dose. The BM...

How do you monitor risk of erythrocytosis from testosterone use for female to male transgender patients?

2
1 Answers

Mednet Member
Mednet Member
Hematology · University of Rochester School of Medicine and Dentistry

I utilize the Endocrine Society's guidelines for identifying secondary erythrocytosis secondary to gender affirming hormone therapy (GAHT) (PMID 28945902). For initial monitoring, at baseline and then every 3 month hematocrit for the first year and 1-2 times yearly thereafter is typically implemente...

How would you approach treatment in a patient with Fanconi anemia and glioblastoma?

1
1 Answers

Mednet Member
Mednet Member
Pediatric Hematology/Oncology · University of Colorado Anschutz Medical Campus

This is challenging due to the sensitivity of Fanconi anemia patients to DNA-damaging treatment. I would maximize resection if possible and then treat with radiation, since it is a mainstay of therapy, despite the risk. I would opt for proton radiation if possible to minimize exposure of normal tiss...

Is it acceptable to treat pediatric Hodgkin's lymphoma with an involved nodal field outside the setting of a clinical trial?

2
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Louisville School of Medicine

It probably is. Although not proven by randomized trial/s in pediatric patients, the practice is accepted in adults. In children where long term morbidity of radiation therapy is of greater concern, it would not be unreasonable to use involved nodal field in combination with chemotherapy.

Is it feasible to treat craniospinal fields with new generation scanning beam-only proton machines?

3 Answers

Mednet Member
Mednet Member
Radiation Oncology · McLaren Proton Therapy Center

Yes, it is feasible to treat craniospinal fields with scanning beam-only technology. Scanning beam proton therapy delivers one discrete Bragg peak "spot" at a time. Large fields require many spots; so treating large fields such as craniospinal fields with scanning beam techniques requires more time ...

Is it preferable to simulate pediatric Hodgkin's lymphoma patients with arms up or akimbo?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Mayo Clinic Florida

We will be moving towards involved site radiotherapy for pediatric Hodgkin lymphoma. Consequently, you may want to match the simulation with the set up of their pre-treatment PET/CT scan (arms up vs arms down). This will allow you to have more certainty regarding the location of axiallary and subpec...